We own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on the US soil and the US government would have the right of first refusal on production on the facility. And when the US government does not want to source material from that facility, the company is free to manufacture other materials and sell it to whoever they wish to sell.
Bank of Maharashtra Q1 Results: Net profit jumps 23% YoY to Rs 1,593 crore
Bank of Maharashtra announced a net profit of Rs 1593 crore for Q1 June 2025, marking a 23% year-over-year increase. Total income rose by 16%
July 15, 2025